New app aims to stop Kids' eyes from getting worse during screen time

NCT ID NCT07390500

Recruiting now Disease control Sponsor: NovaSight Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

The DYMOND study is testing a digital app called TrackSight that may slow myopia (nearsightedness) in children aged 6 to 12. The app uses eye-tracking to keep central vision clear while slightly blurring the edges of the screen, based on principles that influence eye growth. About 150 kids in Israel and Hong Kong will use the app during normal screen time for 12 months to see if it safely slows the worsening of their eyesight.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: TrackSight digital medical application (device)
What this could lead to: If it works, this could offer a non-invasive, screen-based way to slow myopia progression in children, reducing the need for stronger glasses later.
What could go wrong: This is an early Phase 2 trial with only 150 participants, so results may not apply to all children. The effect may be small or not better than no treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MYOPIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

myopia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MYOPIA

Contacts and locations

Locations

Kaplan MC
RECRUITING

Rehovot, Israel

More trials for these conditions

Other studies related to the condition(s) this trial covers.